rs3817672

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001128148.3(TFRC):​c.424G>A​(p.Gly142Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 1,611,674 control chromosomes in the GnomAD database, including 220,542 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 15436 hom., cov: 31)
Exomes 𝑓: 0.52 ( 205106 hom. )

Consequence

TFRC
NM_001128148.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.01

Publications

82 publications found
Variant links:
Genes affected
TFRC (HGNC:11763): (transferrin receptor) This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]
TFRC Gene-Disease associations (from GenCC):
  • TFRC-related combined immunodeficiency
    Inheritance: AR, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.010613E-5).
BP6
Variant 3-196073940-C-T is Benign according to our data. Variant chr3-196073940-C-T is described in ClinVar as Benign. ClinVar VariationId is 1164902.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFRCNM_001128148.3 linkc.424G>A p.Gly142Ser missense_variant Exon 4 of 19 ENST00000360110.9 NP_001121620.1 P02786Q7Z3E0
TFRCNM_003234.4 linkc.424G>A p.Gly142Ser missense_variant Exon 4 of 19 NP_003225.2 P02786A8K6Q8Q7Z3E0
TFRCNM_001313965.2 linkc.181G>A p.Gly61Ser missense_variant Exon 3 of 18 NP_001300894.1 P02786G3V0E5Q7Z3E0
TFRCNM_001313966.2 linkc.-412-1788G>A intron_variant Intron 2 of 16 NP_001300895.1 P02786A0A8V8TM46B7Z2I6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFRCENST00000360110.9 linkc.424G>A p.Gly142Ser missense_variant Exon 4 of 19 1 NM_001128148.3 ENSP00000353224.4 P02786

Frequencies

GnomAD3 genomes
AF:
0.425
AC:
64547
AN:
151876
Hom.:
15433
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.228
Gnomad AMI
AF:
0.357
Gnomad AMR
AF:
0.410
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.552
Gnomad OTH
AF:
0.466
GnomAD2 exomes
AF:
0.449
AC:
112205
AN:
249668
AF XY:
0.458
show subpopulations
Gnomad AFR exome
AF:
0.220
Gnomad AMR exome
AF:
0.351
Gnomad ASJ exome
AF:
0.472
Gnomad EAS exome
AF:
0.144
Gnomad FIN exome
AF:
0.522
Gnomad NFE exome
AF:
0.553
Gnomad OTH exome
AF:
0.490
GnomAD4 exome
AF:
0.522
AC:
761562
AN:
1459680
Hom.:
205106
Cov.:
43
AF XY:
0.520
AC XY:
377245
AN XY:
726008
show subpopulations
African (AFR)
AF:
0.215
AC:
7192
AN:
33426
American (AMR)
AF:
0.359
AC:
15945
AN:
44436
Ashkenazi Jewish (ASJ)
AF:
0.471
AC:
12281
AN:
26058
East Asian (EAS)
AF:
0.183
AC:
7254
AN:
39650
South Asian (SAS)
AF:
0.418
AC:
35956
AN:
86038
European-Finnish (FIN)
AF:
0.515
AC:
27500
AN:
53376
Middle Eastern (MID)
AF:
0.599
AC:
3439
AN:
5746
European-Non Finnish (NFE)
AF:
0.560
AC:
621775
AN:
1110652
Other (OTH)
AF:
0.501
AC:
30220
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
16998
33997
50995
67994
84992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17086
34172
51258
68344
85430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.425
AC:
64554
AN:
151994
Hom.:
15436
Cov.:
31
AF XY:
0.421
AC XY:
31284
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.228
AC:
9442
AN:
41446
American (AMR)
AF:
0.410
AC:
6246
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.473
AC:
1641
AN:
3470
East Asian (EAS)
AF:
0.156
AC:
805
AN:
5166
South Asian (SAS)
AF:
0.404
AC:
1944
AN:
4816
European-Finnish (FIN)
AF:
0.523
AC:
5526
AN:
10572
Middle Eastern (MID)
AF:
0.554
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
0.552
AC:
37487
AN:
67960
Other (OTH)
AF:
0.461
AC:
974
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1781
3562
5343
7124
8905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.501
Hom.:
67720
Bravo
AF:
0.405
TwinsUK
AF:
0.563
AC:
2086
ALSPAC
AF:
0.560
AC:
2159
ESP6500AA
AF:
0.228
AC:
1004
ESP6500EA
AF:
0.546
AC:
4692
ExAC
AF:
0.445
AC:
54070
Asia WGS
AF:
0.309
AC:
1075
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 57. Only high quality variants are reported. -

TFRC-related combined immunodeficiency Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.0
DANN
Benign
0.82
DEOGEN2
Benign
0.0016
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.096
T;.;T
MetaRNN
Benign
0.000050
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-1.6
.;N;N
PhyloP100
-1.0
PrimateAI
Benign
0.30
T
PROVEAN
Benign
1.1
N;N;N
REVEL
Benign
0.022
Sift
Benign
0.58
T;T;T
Sift4G
Benign
0.84
T;T;T
Polyphen
0.0
.;B;B
Vest4
0.020
MPC
0.16
ClinPred
0.0037
T
GERP RS
1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.015
gMVP
0.34
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3817672; hg19: chr3-195800811; COSMIC: COSV64056155; COSMIC: COSV64056155; API